Caregen Biopharma
Korea - AnyangPharmaceutical
Focus: Caregen Biopharma is a Korean-based pharmaceutical company specializing in growth factors and biomimetic peptides for ophthalmology indications. The company operates at pre-revenue stage with an early-stage pipeline focused on wet age-related macular degeneration.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Caregen Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Caregen Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CG-P5 peptide
Age-related Wet Macular DegenerationClinical Trials (1)
NCT06132035Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Phase 1Help build intelligence for Caregen Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.